Functional CD25bright+ alloresponsive T cells in fully immunosuppressed renal allograft recipients

被引:20
作者
Baan, Carla C.
Velthuis, Jurjen H. L.
van Gurp, Evelien A. F. J.
Mol, Wendy M.
Klepper, Mariska
Ijzermans, Jan N. M.
Weimar, Willem
机构
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, NL-3000 DR Rotterdam, Netherlands
关键词
CD4+ CD25(bright+) regulatory T cells; kidney transplantation; patients;
D O I
10.1111/j.1399-0012.2006.00584.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Evidence from animal studies indicate a crucial role for CD25(bright+) regulatory T cells in transplantation tolerance. Methos: To assess whether peripheral CD25(bright+) T cells control immune responses in immunosuppressed kidney transplant patients, we analyzed the suppressive capacities of these cells using mixed lymphocytes reactions. Results: Allogeneic stimulation of patients peripheral blood mononuclear cells was associated with IL-2 production and T-cell proliferation. Depletion of CD25(bright+) T cells resulted in a 35% (median) higher IL-2 production and a 38% higher proliferative response against third party cells, showing that functional regulatory CD25(bright+) T cells were present (p = 0.03 and 0.02 respectively). In eight out of 11 patients, we also demonstrated regulation activity against donor-activated T cells (p = 0.03). These data were confirmed in coculture experiments with isolated CD25(-/dim) T cells plus CD25(bright+) T cells. At a 1:2 ratio, the CD25(bright+) T cells suppressed the proliferation of CD25(-/dim) donor- and third party-stimulated responder T cells. Conclusions: CD25(bright+) T cells with immune regulatory activities against anti-donor-responsive T cells are readily detectable in renal allograft recipients during treatment with full dosage immunosuppression. Whether CD25(bright+) T cells indeed play a role in graft acceptance after organ transplantation in patients remains to be elucidated.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 37 条
[1]  
BAAN CC, 1994, CLIN EXP IMMUNOL, V97, P293
[2]   Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin in human on the induction of FOXP3 T cells [J].
Baan, CC ;
van der Mast, BJ ;
Klepper, M ;
Mol, WM ;
Peeters, AMA ;
Korevaar, SS ;
Balk, AHMM ;
Weimar, W .
TRANSPLANTATION, 2005, 80 (01) :110-117
[3]   Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation [J].
Baan, CC ;
Knoop, CJ ;
van Gelder, T ;
Holweg, CTJ ;
Niesters, HGM ;
Smeets, TJM ;
van der Ham, F ;
Zondervan, PE ;
Maat, LPWM ;
Balk, AHMM ;
Weimar, W .
TRANSPLANTATION, 1999, 67 (06) :870-876
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]   Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].
Battaglia, M ;
Stabilini, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (12) :4743-4748
[6]   Regulatory T-cell therapy: is it ready for the clinic? [J].
Bluestone, JA .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :343-349
[7]   Role of regulatory T cells in human diseases [J].
Chatila, TA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :949-959
[8]   Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells [J].
Coenen, JJA ;
Koenen, HJPM ;
van Rijssen, E ;
Hilbrands, LB ;
Joosten, I .
BLOOD, 2006, 107 (03) :1018-1023
[9]   Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling [J].
D'Cruz, LM ;
Klein, L .
NATURE IMMUNOLOGY, 2005, 6 (11) :1152-1159
[10]   Intragraft interleukin 2 mRNA expression during acute cellular rejection and left ventricular total wall thickness after heart transplantation [J].
de Groot-Kruseman, HA ;
Baan, CC ;
Hagman, EM ;
Mol, WM ;
Niesters, HG ;
Maat, AP ;
Zondervan, PE ;
Weimar, W ;
Balk, AH .
HEART, 2002, 87 (04) :363-367